Lobate Cream contains Clobetasol propionate 0.05% w/w, a potent topical corticosteroid indicated for the treatment of various inflammatory and pruritic dermatoses responsive to corticosteroid therapy. Clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing erythema, swelling, and itching. Lobate Cream is primarily prescribed for conditions such as psoriasis, eczema, lichen planus, and severe dermatitis unresponsive to less potent corticosteroids. The formulation allows for effective skin penetration, providing rapid symptomatic relief. It is intended for short-term use due to the risk of adverse effects associated with potent corticosteroids, including skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression if used extensively or under occlusion. Application should be limited to affected areas, avoiding sensitive regions such as the face, groin, and axillae unless directed by a healthcare professional. Patients should adhere strictly to prescribed dosages and duration to minimize systemic absorption and local side effects. Lobate Cream is contraindicated in untreated bacterial, viral, or fungal skin infections. Caution is advised during pregnancy and lactation, and use in pediatric patients should be under medical supervision. Discontinuation should be gradual to prevent rebound effects.